<?xml version='1.0' encoding='utf-8'?>
<document id="31902291"><sentence text="Metabolic disposition of H3B-8800, an orally available small-molecule splicing modulator, in rats, monkeys, and humans." /><sentence text="H3B-8800, a novel orally available modulator of the SF3b complex, which potently and preferentially kills spliceosome-mutant tumor cells, is in clinical development for the treatment of advanced myeloid malignancies" /><sentence text=" We characterized the pharmacokinetics, metabolism and disposition of H3B-8800 in rats, monkeys and humans" /><sentence text="In vitro, H3B-8800 is a substrate of CYP3A4/5, flavin-containing monooxygenases (FMOs) and P-glycoprotein (P-gp), and showed a favorable drug-drug interaction profile as a perpetrator" /><sentence text="Following oral dosing of 14C-H3B-8800 in bile-duct cannulated SD rats, 54" /><sentence text="7% of the dosed radioactivity was excreted in the bile, with less found in feces (36" /><sentence text="8%)" /><sentence text=" The low amount in urine (3" /><sentence text="7%), suggests that renal elimination is a minor pathway of clearance for H3B-8800" /><sentence text="In Long-Evans rats, radioactivity derived from 14C-H3B-8800 was rapidly absorbed, with the highest distribution in the ocular, metabolic/excretory, and gastrointestinal tract tissues" /><sentence text=" No radioactivity was detected in the central nervous system" /><sentence text="Seven metabolites were observed in human plasma following 4 daily doses of 40â€‰mg H3B-8800" /><sentence text=" H3B-68736 (N-desmethyl), H3B-77176 (N-oxide), and unchanged H3B-8800 were the prominent components in human plasma, at 27"><entity charOffset="12-23" id="DDI-PubMed.31902291.s13.e0" text="N-desmethyl" /><entity charOffset="26-35" id="DDI-PubMed.31902291.s13.e1" text="H3B-77176" /><entity charOffset="37-44" id="DDI-PubMed.31902291.s13.e2" text="N-oxide" /><pair ddi="false" e1="DDI-PubMed.31902291.s13.e0" e2="DDI-PubMed.31902291.s13.e0" /><pair ddi="false" e1="DDI-PubMed.31902291.s13.e0" e2="DDI-PubMed.31902291.s13.e1" /><pair ddi="false" e1="DDI-PubMed.31902291.s13.e0" e2="DDI-PubMed.31902291.s13.e2" /><pair ddi="false" e1="DDI-PubMed.31902291.s13.e1" e2="DDI-PubMed.31902291.s13.e1" /><pair ddi="false" e1="DDI-PubMed.31902291.s13.e1" e2="DDI-PubMed.31902291.s13.e2" /></sentence><sentence text="3%, 18" /><sentence text="1%, and 33" /><sentence text="2%, respectively, of the total drug-related material in a pooled AUC0-24h sample" /><sentence text=" The same 7 metabolites were observed in monkey plasma" /><sentence text="" /></document>